Related Experiment Videos
Tyr³²³-dependent p38 activation is associated with rheumatoid arthritis and correlates with disease activity
Mercedes López-Santalla1, María Salvador-Bernáldez, Isidoro González-Alvaro
1Centro Nacional de Biotecnología, CSIC, Madrid, Spain.
Objective:
The p38 MAPK is important in the pathogenic immune response in rheumatoid arthritis (RA). The p38 molecule can be activated through phosphorylation on Thr¹⁸⁰-Tyr¹⁸² by upstream MAPK kinases and via an alternative pathway through phosphorylation on Tyr³²³. We undertook this study to quantify the phosphorylation of Tyr³²³ p38 and of Thr¹⁸⁰-Tyr¹⁸² p38 on T cells from healthy controls and patients with RA or ankylosing spondylitis (AS) to identify variables associated with p38 phosphorylation and disease activity.
Methods:
We measured p38 phosphorylation on Tyr³²³ and Thr¹⁸⁰-Tyr¹⁸² by flow cytometry and Western blotting on T cells from 30 control subjects, 33 AS patients, 30 patients with RA in remission, and 79 patients with active RA. We collected the clinical characteristics and analyzed correlations between clinical variables, the Disease Activity Score in 28 joints (DAS28), and p38 phosphorylation levels. Multivariate regression analysis was performed to identify variables associated with p38 phosphorylation on Tyr³²³ and Thr¹⁸⁰-Tyr¹⁸².
Results:
Phosphorylation of p38 on Tyr³²³ was higher in T cells from patients with active RA (P = 0.008 versus healthy controls) than in patients with RA in remission or in patients with AS. Tyr³²³ p38 phosphorylation was associated with disease activity determined by the DAS28 (P = 0.017). Enhanced p38 phosphorylation was linked to Lck-mediated activation of the Tyr³²³-dependent pathway in the absence of upstream MAPKK activation.
Conclusion:
Our results indicate that phosphorylation status on Tyr³²³ p38 correlates with RA disease activity and suggest that the Tyr³²³-dependent pathway is an attractive target for down-regulation of p38 activity in RA patients.
Insights
Phosphorylation of p38 on Tyr³²³ is elevated in active rheumatoid arthritis (RA) and linked to disease activity. Targeting this Tyr³²³ pathway may reduce p38 activity in RA patients.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- The p38 mitogen-activated protein kinase (MAPK) pathway plays a critical role in the immune response in rheumatoid arthritis (RA).
- p38 MAPK activation occurs via phosphorylation at Thr¹⁸⁰-Tyr¹⁸² by MAPK kinases (MAPKKs) or through an alternative pathway involving phosphorylation at Tyr³²³.
- Understanding these activation pathways is crucial for developing targeted therapies for RA.
Purpose of the Study:
- To quantify the phosphorylation levels of Tyr³²³ p38 and Thr¹⁸⁰-Tyr¹⁸² p38 in T cells from healthy controls, RA patients, and ankylosing spondylitis (AS) patients.
- To identify clinical variables associated with p38 phosphorylation and disease activity in RA.
- To investigate the relationship between p38 phosphorylation status and disease activity metrics like the Disease Activity Score in 28 joints (DAS28).
Main Methods:
- Flow cytometry and Western blotting were used to measure p38 phosphorylation on Tyr³²³ and Thr¹⁸⁰-Tyr¹⁸².
- T cells were analyzed from 30 healthy controls, 33 AS patients, 30 RA patients in remission, and 79 patients with active RA.
- Clinical characteristics were collected, and multivariate regression analysis was performed to correlate p38 phosphorylation with clinical variables and DAS28 scores.
Main Results:
- Tyr³²³ p38 phosphorylation was significantly higher in T cells from patients with active RA compared to healthy controls (P = 0.008) and RA patients in remission.
- Increased Tyr³²³ p38 phosphorylation positively correlated with RA disease activity as measured by DAS28 (P = 0.017).
- Enhanced p38 phosphorylation via the Tyr³²³-dependent pathway was associated with Lck-mediated activation, independent of upstream MAPKK activation.
Conclusions:
- The phosphorylation status of Tyr³²³ p38 is a potential biomarker that correlates with disease activity in rheumatoid arthritis.
- The Tyr³²³-dependent p38 activation pathway represents a promising therapeutic target for down-regulating p38 activity in RA patients.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis